Home Depot reported Q2 results on August 18 and the stock has largely absorbed the print without drama, leaving the post-earnings analyst flurry as the most interesting story this week.
The analyst response to the Q2 numbers landed almost entirely on the same side. Most firms maintained Buy-equivalent ratings and held or nudged targets higher. Mizuho raised its target to $390 from $385 while keeping an Outperform rating, and Truist lifted to $373 from $369 with a Buy. UBS trimmed to $420 from $430 but stayed at Buy — the clearest sign that the number slightly disappointed on some line without changing the directional thesis. Only RBC held back, shaving its target by a dollar to $342 with a Sector Perform, the lone explicitly cautious voice among today's crowd. The consensus target now sits at roughly $377, a 12% premium to the current $337.49 close — meaningful upside on paper, though the stock has traded at a discount to consensus for most of this year. The bull case rests on Pro ecosystem momentum and the SRS Distribution acquisition layering in revenue; the bear case is the familiar one — housing turnover is still slow, rate-sensitive DIY demand has not recovered, and the top-line inflection remains more hoped for than evidenced.
Options positioning, which was the lead story in each of the three notes leading into Tuesday's print, has shifted modestly but not materially. The put/call ratio ticked up to 0.88 — about 1.5 standard deviations above its 20-day average of 0.82 — the highest reading in the options history shown here. Before earnings, that hedging read as pre-print caution. After the fact, it reads as something slightly different: protection that didn't pay out on a dramatic down-move but also hasn't been unwound. The PCR was running in the mid-to-high 0.76s through late July; it never retreated after the print, which suggests the options market is still not fully relaxed on the near-term path. The borrow market, as has been the case throughout August, adds nothing to the discussion — availability is effectively uncapped at over 830 million shares available to lend, short interest is 1.2% of the float, and cost to borrow is 0.43%. There is no squeeze dynamic and no signal from the lending side worth emphasising.
The price action since the print is worth noting for what it isn't. HD closed Tuesday at $337.49, down just 0.1% on the day and down 4.8% on the week — almost all of that weekly loss was accumulated before the results, not after. The stock entered earnings having already shed nearly $17 from the $354 level it held at the start of August, so the print essentially hit a stock that had pre-emptively repriced lower. Closest peer LOW fell 2.5% on the week, while FND dropped 7.4% — suggesting the sector-wide softness is real, but HD held up relatively better than some of the more rate-sensitive names. WSM was off 3.7%. The relative resilience after the print, given the pre-earnings slide, is the most constructive data point available.
Valuation is incrementally cheaper than it was a month ago. The price-to-earnings multiple has compressed about 0.15 points over 30 days, and the price-to-book has eased as well. Neither move is dramatic, but both nudge in the direction the bulls need — if earnings estimates hold and the multiple stabilises here around 21.6x, the stock's 12% discount to the consensus target becomes a more straightforward arithmetic argument. Factor scores show a high dividend rank of 80 and a reasonably strong forward EPS growth signal, while near-term EPS momentum scores are below average at 40 and 36 for the 30- and 90-day windows. That combination — solid yield and long-term growth credentials, soft near-term estimate momentum — neatly maps to the Street's split between raising and holding targets in a single session.
The next formal event is the Q3 print, flagged for November 17. Between now and then, the housing market data — existing home sales, mortgage application trends, and any Federal Reserve messaging on rates — will be what moves the needle on whether the bull case gets any fundamental validation before the next quarter.
See the live data behind this article on ORTEX.
Open HD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
